BackgroundCheck.run
Search For

Ping Lai LiUncasville, CT

Known as:
Ping Lilai
Related to:
Jian Liu 75 Li Ting Wang 38

Ping Li Phones & Addresses

Uncasville, CT   

13642 Maple Ave, Flushing, NY 11355    718-4603534   

Brooklyn, NY   

Work

Company: Chous consolidated enterprise Address: 4203 162Nd St, Flushing, NY 11358 Phones: 718-3538818 Position: Founder Industries: Hats, Caps, and Millinery
Get Report
Control this profile

Mentions for Ping Lai Li

Career records & work history

Medicine Doctors

Ping Li

Specialties:
Neurology
Work:
University Of NeurologyJacobs Neurological Institute
5851 Main St, Buffalo, NY 14221
716-9326080 (phone) 716-3324245 (fax)
Site
University Neurology Inc
100 High St STE D2, Buffalo, NY 14203
716-8597540 (phone) 716-8597833 (fax)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1997
Procedures:
Sleep and EEG Testing
Conditions:
Epilepsy, Peripheral Nerve Disorders, Dementia, Hemorrhagic stroke, Migraine Headache, Multiple Sclerosis (MS), Obstructive Sleep Apnea, Parkinson's Disease
Languages:
English, Spanish
Description:
Dr. Li graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1997. She works in Buffalo, NY and 1 other location and specializes in Neurology. Dr. Li is affiliated with Buffalo General Medical Center and Roswell Park Cancer Institute Hospital.

Ping Li

Specialties:
Nephrology
Work:
Washington DC VA Medical Center Primary Care Clinic
50 Irving St NW, Washington, DC 20422
202-7458163 (phone) 202-5184690 (fax)
Education:
Medical School
Inner Mongolia Med Coll, Hohhot City, Inner Mongolia Auto Reg, China
Graduated: 1986
Procedures:
Dialysis Procedures
Conditions:
Acute Pancreatitis, Acute Renal Failure, Anemia, Atrial Fibrillation and Atrial Flutter, Bacterial Pneumonia, Benign Prostatic Hypertrophy, Bronchial Asthma, Calculus of the Urinary System, Cardiac Arrhythmia, Cardiomyopathy, Cholelethiasis or Cholecystitis, Chronic Bronchitis, Chronic Renal Disease, Constipation, Dementia, Diabetes Mellitus (DM), Diverticulitis, Gastrointestinal Hemorrhage, Gout, Heart Failure, Hypertension (HTN), Hypothyroidism, Ischemic Bowel Disease, Ischemic Heart Disease, Malignant Neoplasm of Female Breast, Migraine Headache, Obstructive Sleep Apnea, Osteomyelitis, Overweight and Obesity, Pneumonia, Poisoning by Drugs, Meds, or Biological Substances, Septicemia, Skin and Subcutaneous Infections, Substance Abuse and/or Dependency, Transient Cerebral Ischemia, Urinary Tract Infection (UT), Vitamin D Deficiency
Languages:
English, French, Spanish
Description:
Dr. Li graduated from the Inner Mongolia Med Coll, Hohhot City, Inner Mongolia Auto Reg, China in 1986. He works in Washington, DC and specializes in Nephrology. Dr. Li is affiliated with Washington DC VA Medical Center.

License Records

Ping Li

Address:
61-36 170 St Apt2C, Fresh Meadows, NY
Phone:
718-5701107
Licenses:
License #: 68830 - Active
Category: Health Care
Issued Date: May 17, 2012
Effective Date: Jun 17, 2015
Expiration Date: Aug 31, 2017
Type: Massage Therapist

Ping Li

Address:
13425 Franklin Ave APT 422, Flushing, NY
Phone:
646-2623166
Licenses:
License #: 65547 - Active
Category: Health Care
Issued Date: Oct 13, 2011
Effective Date: Oct 13, 2011
Expiration Date: Aug 31, 2017
Type: Massage Therapist

Ping Li

Address:
132-03 Sanford Ave APT 6G, Flushing, NY
Phone:
347-4868332
Licenses:
License #: 77497 - Active
Category: Health Care
Issued Date: Sep 30, 2014
Effective Date: Sep 30, 2014
Expiration Date: Aug 31, 2019
Type: Massage Therapist

Publications & IP owners

Us Patents

Pharmaceutical Formulations

US Patent:
2019005, Feb 21, 2019
Filed:
Mar 14, 2018
Appl. No.:
15/921306
Inventors:
- Boulder CO, US
Yogita Krishnamachari - Springfield NJ, US
Xiaohong Shen - Livingston NJ, US
Hanchen Lee - Teaneck NJ, US
Ping Li - Basking Ridge NJ, US
Rajinder Singh - Sewaren NJ, US
LayChoo Tan - Bridgewater NJ, US
International Classification:
A61K 31/506
A61K 9/20
A61K 9/00
A61K 9/28
A61K 9/48
Abstract:
This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2- yl)carbamate (COMPOUND A) and the use of these formulations for treating proliferative diseases, such as solid tumor diseases.

Multiplatform Gmti Radar With Adaptive Clutter Suppression

US Patent:
2018003, Feb 1, 2018
Filed:
Sep 26, 2017
Appl. No.:
15/715492
Inventors:
- North Syracuse NY, US
Ping G. Li - Elmhurst NY, US
Assignee:
SRC, Inc. - North Syracuse NY
International Classification:
G01S 13/524
G01S 7/288
G01S 13/87
G01S 13/00
Abstract:
The present invention is directed to a method for processing radar signals in a distributed array radar that includes a first airborne platform and at least one second airborne platform. Doppler filtered radar return samples are obtained and a weight value is calculated as a function of first clutter signals and second clutter signals. The weight value is employed in a weight vector that is computed, as well, from a steering vector that need not be matched to the target vector. The weight vector is applied to a signal vector corresponding to the Doppler filtered radar return samples. An open loop feedback is implemented and configured to create beam pattern nulls at angles corresponding to the plurality of first interference signals within each of the Doppler bins without substantially tracking a position or velocity of the first airborne platform or the at least one second airborne platform.

Pharmaceutical Formulations

US Patent:
2017020, Jul 20, 2017
Filed:
Mar 7, 2017
Appl. No.:
15/452239
Inventors:
- Boulder CO, US
Yogita Krishnamachari - Springfield NJ, US
Xiaohong Shen - Livingston NJ, US
Hanchen Lee - Teaneck NJ, US
Ping Li - Basking Ridge NJ, US
Rajinder Singh - Sewaren NJ, US
LayChoo Tan - Bridgewater NJ, US
International Classification:
A61K 31/506
A61K 9/20
A61K 9/28
A61K 9/48
Abstract:
This invention relates to solid oral pharmaceutical formulations or(S)-methyl ((4(4-(3-(5-chtoro-2-fluoro-3-(methyl-sutfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of these formulations for treating proliferative diseases, such as solid tumor diseases.

Multiplatform Gmti Radar With Adaptive Clutter Suppression

US Patent:
2017010, Apr 13, 2017
Filed:
Jun 9, 2014
Appl. No.:
14/299399
Inventors:
- North Syracuse NY, US
Ping G. Li - Elmhurst NY, US
Assignee:
SRC, INC. - North Syracuse NY
International Classification:
G01S 13/524
G01S 7/288
G01S 13/00
Abstract:
The present invention is directed to a method for processing radar signals in a distributed array radar that includes a first airborne platform and at least one second airborne platform. Doppler filtered radar return samples are obtained and a weight value is calculated as a function of first clutter signals and second clutter signals. The weight value is employed in a weight vector that is computed, as well, from a steering vector that need not be matched to the target vector. The weight vector is applied to a signal vector corresponding to the Doppler filtered radar return samples. An open loop feedback is implemented and configured to create beam pattern nulls at angles corresponding to the plurality of first interference signals within each of the Doppler bins without substantially tracking a position or velocity of the first airborne platform or the at least one second airborne platform.

Pharmaceutical Formulations

US Patent:
2016027, Sep 29, 2016
Filed:
Jun 10, 2016
Appl. No.:
15/179190
Inventors:
- Basel, CH
Yogita Krishnamachari - Springfield NJ, US
Xiaohong Shen - Livingston NJ, US
Hanchen Lee - Teaneck NJ, US
Ping Li - Basking Ridge NJ, US
Rajinder Singh - Sewaren NJ, US
LayChoo Tan - Bridgewater NJ, US
International Classification:
A61K 31/506
A61K 9/48
A61K 9/20
A61K 9/00
Abstract:
This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methyl sulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of these formulations for treating proliferative diseases, such as solid tumor diseases.

Transgenic Plants With Enhanced Agronomic Traits

US Patent:
2016027, Sep 22, 2016
Filed:
Mar 21, 2016
Appl. No.:
14/999032
Inventors:
- St. Louis MO, US
Thandoni Rao Ambika - Bangalore, IN
Erin Bell - St. Louis MO, US
Kraig Brustad - Stonington CT, US
R. Eric Cerny - Chesterfield MO, US
Shobha Char - Bangalore, IN
Paul S. Chomet - Mystic CT, US
Julie Davis - North Stonington CT, US
Molian Deng - Grover MO, US
Todd DeZwaan - Apex NC, US
Michael D. Edgerton - St. Louis MO, US
Karen Gabbert - St. Louis MO, US
Barry S. Goldman - St. Louis MO, US
Brian Hauge - Wildwood MO, US
Steve He - St. Louis MO, US
Jacqueline E. Heard - Stonington CT, US
Alberto Iandolino - Davis CA, US
Ping Li - St. Peters MO, US
Linda L. Lutfiyya - St. Louis MO, US
Savitha Madappa - Bangalore, IN
Brad McDill - Smithton IL, US
Robert J. Meister - St. Peters MO, US
Peter Morrell - Chesterfield MO, US
Anil Neelam - Wildwood MO, US
Marie Petracek - Glendale MO, US
John Pitkin - Wildwood MO, US
M. S. Rajani - St. Louis MO, US
Dhanalakshmi Ramachandra - Bangalore, IN
Monica P. Ravanello - Fairfield CA, US
Maria F. Rodriguez - Kirkwood MO, US
Thomas G. Ruff - Wildwood MO, US
Sangeetha Singh - Bangalore, IN
Virginia Ursin - Pawcatuck CT, US
Kammaradi R. Vidya - Bangalore, IN
K. Vijayalakshmi - Bangalore, IN
Xiaoyun Wu - Chesterfield MO, US
Jianmin Zhao - St. Louis MO, US
International Classification:
C12N 15/82
C07K 14/415
G01N 33/68
C12Q 1/68
Abstract:
This invention provides transgenic plant cells with recombinant DNA for expression of proteins that are useful for imparting enhanced agronomic trait(s) to transgenic crop plants. This invention also provides transgenic plants and progeny seed comprising the transgenic plant cells where the plants are selected for having an enhanced trait selected from the group of traits consisting of enhanced water use efficiency, enhanced cold tolerance, increased yield, enhanced nitrogen use efficiency, enhanced seed protein and enhanced seed oil. Also disclosed are methods for manufacturing transgenic seed and plants with enhanced traits.

Pharmaceutical Formulations

US Patent:
2014030, Oct 16, 2014
Filed:
Nov 21, 2012
Appl. No.:
14/359121
Inventors:
- Basel, CH
Xiaohong Shen - Livingston NJ, US
Hanchen Lee - Teaneck NJ, US
Ping Li - Basking Ridge NJ, US
Rajinder Singh - Sewaren NJ, US
LayChoo Tan - Bridgewater NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/506
US Classification:
514275, 544331
Abstract:
This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (COMPOUND A) and the use of the formulations for treating proliferative diseases, such as solid tumor diseases.

Zea Mays Nfb2 Promoter

US Patent:
2009013, May 28, 2009
Filed:
Dec 9, 2008
Appl. No.:
12/331214
Inventors:
Donald E. Nelson - Stonington CT, US
Brendan S. Hinchey - Mystic CT, US
Michelle Lacy - St. Louis MO, US
James A. Morrell - St. Louis MO, US
Andrey A. Boukharov - Wildwood MO, US
Zhaolong Li - St. Louis MO, US
Wei Wu - St. Louis MO, US
Linda Lutfiyya - St. Louis MO, US
Maolong Lu - St. Louis MO, US
David K. Kolavic - Clayton MO, US
Qi Wang - St. Louis MO, US
Ping Li - St. Peters MO, US
Yongwei Cao - Chesterfield MO, US
International Classification:
A01N 57/18
A01H 5/00
C07H 21/04
A01P 21/00
C12N 15/82
C12N 5/10
US Classification:
504204, 800298, 8003202, 8003201, 8003203, 800320, 8003172, 8003173, 8003174, 800312, 800314, 800322, 536 241, 4353201, 435419, 435412
Abstract:
The present invention provides non-coding regulatory element polynucleotide molecules isolated from the transcription factor Nuclear Factor B (NFB2) gene of and useful for expressing transgenes in plants. The invention further discloses compositions, polynucleotide constructs, transformed host cells, transgenic plants and seeds containing the NFB2 regulatory polynucleotide sequences, and methods for preparing and using the same.

Isbn (Books And Publications)

The Handbook Of East Asian Psycholinguistics: Japanese

Author:
Ping Li
ISBN #:
0521833337

The Handbook Of East Asian Psycholinguistics: Japanese

Author:
Ping Li
ISBN #:
0521833345

Model-Based Reasoning In Science, Technology, And Medicine

Author:
Ping Li
ISBN #:
3540719857

Yin Hang Fa Xin Shi Yu Li Jie

Author:
Ping Li
ISBN #:
7805935327

Possible Relatives

Cynthia M Li  David Li  Dawei Li  Dayu W Li  De Li  Dean Li  Da Li  Ping Lam  Ping T Meng  Ping P Lau 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.